نمایش مختصر رکورد

dc.contributor.authorDehghan Manshadi, Zahraen_US
dc.contributor.authorHamid, Mohammaden_US
dc.contributor.authorKosari, Fariden_US
dc.contributor.authorTayebinia, Heidaren_US
dc.contributor.authorKhodadadi, Irajen_US
dc.date.accessioned1399-07-09T00:04:04Zfa_IR
dc.date.accessioned2020-09-30T00:04:04Z
dc.date.available1399-07-09T00:04:04Zfa_IR
dc.date.available2020-09-30T00:04:04Z
dc.date.issued2018-04-01en_US
dc.date.issued1397-01-12fa_IR
dc.date.submitted2017-05-30en_US
dc.date.submitted1396-03-09fa_IR
dc.identifier.citationDehghan Manshadi, Zahra, Hamid, Mohammad, Kosari, Farid, Tayebinia, Heidar, Khodadadi, Iraj. (2018). The Relationship between Matrix Metalloproteinase Gene Polymorphisms and Tumor Type, Tumor Size, and Metastasis in Women with Breast Cancer in Central Iran. Middle East Journal of Cancer, 9(2), 123-131. doi: 10.30476/mejc.2018.42114en_US
dc.identifier.issn2008-6709
dc.identifier.issn2008-6687
dc.identifier.urihttps://dx.doi.org/10.30476/mejc.2018.42114
dc.identifier.urihttps://mejc.sums.ac.ir/article_42114.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/169067
dc.description.abstractBackground: Matrix metalloproteinases-2 and -9 play important roles in the development of breast cancer by hydrolyzing the extracellular matrix. Since −1306C/T and −1562C/T polymorphisms are located at the promoter regions of the matrix metalloproteinase- 2 and -9 genes, respectively, C to T substitution may affect promoter activity and impact the rate of extracellular matrix degradation and cancerous cell proliferation. Therefore, we aimed to determine the genotype and allele frequencies of these polymorphisms in Iranian healthy women and women with breast cancer. We have also examined the correlation of genotypes with clinicopathological parameters such as tumor type, tumor size, and metastasis to lymph nodes.Methods: This case-control study enrolled 200 women with breast cancer and 200 age-matched healthy women. DNA was extracted, and we determined the genotype and allele frequencies of −1306C/T matrix metalloproteinase-2 and −1562C/T matrix metalloproteinase-9 polymorphisms by the polymerase chain reaction-restriction fragment length polymorphism method. Additionally, tumor size (20 mm), tumor type (ductal/non-ductal), and metastasis (yes/no) were determined.Results: Genotype and allele frequencies of the −1306C/T matrix metalloproteinase- 2 polymorphism showed no significant association with the occurrence of breast cancer. Genotype and allele distribution differed in the −1562C/T matrix metalloproteinase- 9 polymorphism and indicated a 4.83-fold increase in the risk of breast cancer for T allele carriers. There was no likelihood of any interaction found between the two polymorphisms and susceptibility to breast cancer. In addition, the −1562C/T matrix metalloproteinase-9 T allele showed an association with metastasis to lymph nodes but we observed no association between the −1306C/T matrix metalloproteinase- 2 polymorphism and clinicopathological features.Conclusion: The ‒1562C/T matrix metalloproteinase-9 polymorphism is involved in the pathogenesis of breast cancer in Iranian women. The T allele may increase the risk of disease.en_US
dc.languageEnglish
dc.language.isoen_US
dc.publisherShiraz University of Medical Sciencesen_US
dc.relation.ispartofMiddle East Journal of Canceren_US
dc.relation.isversionofhttps://dx.doi.org/10.30476/mejc.2018.42114
dc.titleThe Relationship between Matrix Metalloproteinase Gene Polymorphisms and Tumor Type, Tumor Size, and Metastasis in Women with Breast Cancer in Central Iranen_US
dc.typeTexten_US
dc.typeOriginal Articleen_US
dc.contributor.departmentDepartment of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iranen_US
dc.contributor.departmentDepartment of Molecular Medicine, Pasteur Institute of Iran, Tehran, Iranen_US
dc.contributor.departmentPathology Laboratory, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iranen_US
dc.contributor.departmentDepartment of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iranen_US
dc.contributor.departmentDepartment of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iranen_US
dc.citation.volume9
dc.citation.issue2
dc.citation.spage123
dc.citation.epage131
nlai.contributor.orcid0000-0001-9048-4528


فایل‌های این مورد

فایل‌هااندازهقالبمشاهده

فایلی با این مورد مرتبط نشده است.

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد